A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status

NCT01283386 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Leukemia, Chronic

Interventions

DRUG: Chlorambucil
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab

Sponsor

Hoffmann-La Roche